Genalyte receives CE mark for its Maverick Detection System
The company has also signed the first European distribution agreements for MDS with Mokascience in France, Bucher Biotec in Switzerland and KRD Molecular Technologies in the Czech Republic,

The company has also signed the first European distribution agreements for MDS with Mokascience in France, Bucher Biotec in Switzerland and KRD Molecular Technologies in the Czech Republic,

Ekahau Wi-Fi-based temperature sensors and Ekahau Vision software will help the Hutchinson Center to monitor and report the temperatures of several hundred refrigeration units housing specimens used in

The first subject of the study is administered with defibrotide by the medical team from National University Corporation Hamamatsu University School of Medicine (HSUM), Fukushima Medical University. The

The award is intended to support the discovery of a novel series of potent compounds targeting drug abuse and alleviate pain. Dalton Medicinal Chemistry co-founder Judd Berman said,

Clean air and isolator technologies will use G-CON’s mobile cleanroom PODs and Howorth’s advanced expertise in engineering to enable customers to meet safety and regulatory needs without risking

Cegedim’s Mobile Intelligence via the cloud empowers companies with a centralized platform to consolidate interactions, improve governance and enhance strategy execution. Aptalis Pharma International Specialty Pharmaceuticals president Jean-Louis

The collaboration aims at the joint development of technologies for the production of medical isotopes and the marketing and distribution of related isotopes, equipment and services. AMIC chairman

Arcion developed the patented topical gel formulation of clonidine, that is believed to play a vital role in stimulating an inhibitory receptor in the skin connected with pain

The regulatory body has approved Arzerra to treat patients with relapsed / refractory CD20-positive chronic lymphocytic leukemia (CLL). Genmab chief executive officer Jan van de Winkel said, "We

Sucanon, which is a dietary supplement containing natural ingredients, is an oral type-II diabetes treatment. PharmaRoth CEO Luis Lopez said that the filing of the application is a